Home -
Products -
Others -
Other Targets -
((2-(1H-tetrazol-5-yl)-[1,1-biphenyl]-4-yl)methyl)-L-valine
((2-(1H-tetrazol-5-yl)-[1,1-biphenyl]-4-yl)methyl)-L-valine
CAS No. 676129-92-3
((2-(1H-tetrazol-5-yl)-[1,1-biphenyl]-4-yl)methyl)-L-valine( ——— )
Catalog No. M39563 CAS No. 676129-92-3
Devaleryl Valsartan Impurity is an intermediate in the synthesis of Valsartan.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 10MG | 526 | In Stock |
|
| 25MG | Get Quote | In Stock |
|
| 50MG | Get Quote | In Stock |
|
| 100MG | Get Quote | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product Name((2-(1H-tetrazol-5-yl)-[1,1-biphenyl]-4-yl)methyl)-L-valine
-
NoteResearch use only, not for human use.
-
Brief DescriptionDevaleryl Valsartan Impurity is an intermediate in the synthesis of Valsartan.
-
DescriptionDevaleryl Valsartan Impurity is an intermediate in the synthesis of Valsartan.
-
In Vitro———
-
In Vivo———
-
Synonyms———
-
PathwayOthers
-
TargetOther Targets
-
Recptor———
-
Research Area———
-
Indication———
Chemical Information
-
CAS Number676129-92-3
-
Formula Weight351.4
-
Molecular FormulaC19H21N5O2
-
Purity>98% (HPLC)
-
SolubilityDMSO : 250 mg/mL (711.44 mM; ultraphonic; )
-
SMILES———
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
-
Tibesaikosaponin V
Tibesaikosaponin V (TKV) is a triterpene diglycoside, which can be isolated from the methanol extract of the roots of Bupleurum chinense DC.. Tibesaikosaponin V inhibits lipid accumulation and triacylglycerol content occurred without cytotoxicity to adipocytes. Tibesaikosaponin V suppresses the mRNA expression of nuclear transcription factors, such as peroxisome proliferator-activated receptor γ (PPARγ) and CCAAT/enhancer binding protein α (C/EBPα). Tibesaikosaponin V inhibits 3T3-L1 preadipocyte differentiation. Tibesaikosaponin V can be used fro research of obesity and its associated metabolic disorders.
-
GPI-1485
GPI-1485 (GM1485) is a nonimmunosuppressive immunophilin ligand, promoting neurofunctional improvement and neural regeneration following stroke.
-
AA92593
AA92593 has been used as a selective inhibitor of melanopsin.The involvement of melanopsin in the regulation of melatonin was also determined by using a specific inhibitor AA92593 and by inhibiting melanopsin-induced phospholipase C activation.
Cart
sales@molnova.com